Damage in the ANCA-associated vasculitides: Long-term data from the European Vasculitis Study Group (EUVAS) therapeutic trials
Objectives: To describe short-term (up to 12 months) and long-term (up to 7 years) damage in patients with newly diagnosed antineutrophil-cytoplasm antibodyassociated vasculitis (AAV).
| Auteurs principaux: | , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Langue: | English |
| Publié: |
BMJ Publishing Group
2015
|